
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

A recent study published in JMIR AI suggests that machine learning can accurately determine a patient's biological sex and estimate their physiological lung age from pulmonary function tests (PFTs). This lung age prediction approach provides a more intuitive understanding of respiratory health compared to traditional metrics. Consequently, clinicians may soon use these artificial intelligence models to enhance patient communication and monitoring.
Researchers from the Mayo Clinic analyzed retrospective data from 6,392 healthy adults across three regions. They developed gradient-boosted machine models to analyze various PFT parameters, including time-series features. The goal was to determine if artificial intelligence could go beyond standard interpretation to reveal underlying biological patterns related to aging and sex.
The most advanced model achieved a mean absolute error of only 5.55 years in predicting chronological age. Moreover, the sex classification model demonstrated exceptional performance with an area under the curve (AUC) of 0.981. Key predictors for these models included peak expiratory flow, height, and residual volume as a percentage of total lung capacity. Therefore, these findings suggest that AI can extract highly specific physiological markers from routine lung tests.
Although the models tended to overestimate age in younger individuals and underestimate it in older adults, they consistently followed chronological trends. This suggests that physiological lung age could become a valuable biomarker for monitoring lung aging and overall wellness. Furthermore, the ability to predict biological sex with 91.7% sensitivity highlights the profound anatomical differences captured by PFT data.
In conclusion, the integration of AI into pulmonary diagnostics offers a promising pathway for personalized medicine. However, further validation in diverse patient populations is necessary before widespread clinical adoption. Ultimately, this technology could revolutionize how we interpret lung function and manage chronic respiratory conditions.
AI models analyze complex patterns within PFT data, such as airflow volume and capacity. They compare these metrics against large datasets to determine how closely a person's lung function matches specific age groups, resulting in a lung age prediction.
Lung age offers an easy-to-understand metric for patients. This can potentially increase motivation for smoking cessation or adherence to respiratory treatments by making the impact of lung health more tangible.
Currently, these AI models are designed to supplement traditional interpretation. They provide additional context regarding physiological aging rather than replacing standard clinical diagnosis.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Johnson PW et al. Estimating a Physiological Lung Function Score and Biological Sex Using Pulmonary Function Tests and Machine Learning: Retrospective Study. JMIR AI. 2026 Jun 01. doi: 10.2196/89060. PMID: 42224015.
Topalovic M, et al. Artificial intelligence for interpreting pulmonary function tests. Eur Respir J. 2019;53(3):1801703. doi: 10.1183/13993003.01703-2018.
American Thoracic Society. Standardizing PFT Interpretation. 2022.

Mayo Clinic researchers developed AI models to predict lung age and sex from PFT data, achieving high accuracy and offering a new way to assess lung health....
Last week

A recent study shows that seasonal vaccines boost antibody titres against H3N2 subclade K variants in adults. This research highlights why human serologic data is essential for accurate vaccine strain selection compared to ferret models.
Today

A nationwide Belgian study reveals that while invasive lobular carcinoma (ILC) has comparable 5-year survival to other breast cancers, its 10-year prognosis is significantly worse, particularly due to late recurrences in Luminal subtypes.
Today

Evidence suggests SGLT2 inhibitors may offer a disease-modifying strategy for aortic stenosis. By targeting valve calcification and myocardial remodeling, these drugs could slow disease progression and improve outcomes in patients with chronic pressure overload.
Today

A prospective study (SCOL Study) evaluates how different levels of anesthesia depth (BIS 60 vs 40) impact motor evoked potentials (TcMEP) in youths. Findings suggest that while deeper anesthesia alters signal parameters, it does not hinder successful surgeon-directed interpretation.
Today

Exploratory analyses of the JAVELIN Bladder 100 trial confirm that avelumab first-line maintenance significantly improves overall survival in advanced urothelial carcinoma patients with high BMI or diabetes mellitus, maintaining a consistent safety profile.
Today